Drug efficacy is questioned.. Variation in drug responses.

Slides:



Advertisements
Similar presentations
1. 2 ACEI inhibit angiotensin converting enzyme in the body. ACEI inhibit angiotensin converting enzyme in the body. Enzyme maintains balance between:
Advertisements

Problems in Geriatric Pharmacotherapy
Drug Action Across the Life Span
CZ5225 Methods in Computational Biology Lecture 9: Pharmacogenetics and individual variation of drug response CZ5225 Methods in Computational Biology.
Mosby items and derived items © 2005, 2002 by Mosby, Inc. CHAPTER 3 Life Span Considerations NDEG 26 A – Pharmacology 1 Eliza Rivera-Mitu, RN, MSN.
Principles of Drug Use in the Elderly Alastair Stephens Sophie Rozwadowski.
Drugs Used During Pregnancy & Lactation
Personalized Medicine: Using a patient’s genomic information (as well as other physiological parameters) to improve the safety and efficacy of pharmacological.
Polypharmacy of Older Adults
Therapeutic Drug Monitoring (TDM)
Patterns of Prescription Drug Use among Older Adults Arlene S. Bierman, MD, MS Ontario Women’s Health Council Chair in Women’s Health Centre for Research.
Copyright © 2015 Cengage Learning® Chapter 27 Drugs and Older Adults.
CHAPTER 3 Life Span Considerations
Lifespan Considerations
PHARMACOLOGY AND THE OLDER PATIENT David J. Mokler, Ph.D. Department of Pharmacology College of Osteopathic Medicine University of New England.
Pharmacotherapy in the Elderly Paola S. Timiras May, 2007.
Pharmacotherapy in the Elderly Judy Wong
Dr AZZA ELSHERBINY Assistant professor of pharmacology.
Includes adults >65 years old Fastest growing population in US and in the majority of developed nations. 20% of hospitalizations for those >65 are due.
Pharmacology in the Elderly. Pharmacological Challenges in the Elderly  Pharmacokinetic changes  Pharmacodynamic changes  Multiple co-morbidities 
Geriatric Pharmacotherapy
Yasar Kucukardali Professor, Internal Medicine Yeditepe University.
Supported by DHHS/HRSA/BHPr/Division of Nursing Grant #D62HP06858 Best Nursing Practices in Care for Older Adults ELDER Project Fairfield University School.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 10 Drug Therapy in Pediatric Patients.
Factors Affecting Drug Activity Chapter 11 Pages
POLYPHARMACY Pio L. Oliverio, MD Fellow, Geriatrics SVCMC, Jamaica, NY
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 11 Drug Therapy in Geriatric Patients.
Food-Drug Interactions Chapter 19. © 2004, 2002 Elsevier Inc. All rights reserved. Key Terms n Bioavailability: degree to which a drug or other substance.
Objectives Describe the main physiological changes that occur with aging Identify factors affecting absorption and distribution with the geriatric client.
Chapter 35 Safe Medication Use. Drugs Commonly Used by Older Adults Cardiovascular agents Antihypertensives Analgesics Antiarthritic agents Sedatives.
Chapter 5 Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1.
NICHD Perspective on Needs for the Study of Therapeutic Drug Use in Pregnancy Catherine Y Spong, MD PPB, CRMC, NICHD, NIH.
DR. SHABANA ALI (Associate Professor) FACTORS MODIFYING DRUG ACTONS.
Problems of Polypharmacy
RATIONAL DRUG THERAPY DR.SELVAN. INTRODUCTION Choosing a safe and effective treatment regimen for pediatric patients can be challenging. Multiple patient.
Copyright © 2013, 2010 by Saunders, an imprint of Elsevier Inc. Chapter 8 Individual Variation in Drug Responses.
Pharmacogenetics & Pharmacogenomics Personalized Medicine.
Lifespan and Cultural Modifications Copyright © 2013, 2010, 2006, 2003, 2000, 1995, 1991 by Mosby, an imprint of Elsevier Inc. 1 Chapter 5.
門診處方討論 Fludrocortisone (Florinef) 用於 Orthostatic hypotension 報告者 : 黃玉鈴
PHARMACOKINETICS Part 3.
Special Populations: Pediatrics Arthur G. Roberts.
VARIABILITY IN PHARMACOKINETICS & PATIENT RESPONSE Dr. Mohd B. Makmor Bakry, Ph.D., RPh Senior Lecturer in Clinical Pharmacy Universiti Kebangsaan Malaysia.
Age Changes By Sue Henderson.
Pediatric Drug Therapy Cortez,Anne; Cortez,Feliza; Cristi, Frances; Cruz,Denise; Cruz,Ferdinand; Cruz,Karen; Cruz,Belle; Cruz,Mary; Cua,Ronald.
CLINICAL PHARMACY AGE FACTORS: FEATURES OF THE RATIONAL USE OF MEDICINES.
Factoid: Is there a difference in blood flow (Q) between an athlete and non- athlete? Blood flow increases during exercise. At rest, blood flow is similar.
Age Changes By Sue Henderson. Pharmacokinetics How body acts on drug: Reduced renal function, resulting in reduced elimination of renally excreted drugs.
TDM Therapeutic Drug Monitoring
Mosby items and derived items © 2007, 2005, 2002 by Mosby, Inc., an affiliate of Elsevier Inc. CHAPTER 3 Life Span Considerations.
Challenges to drug design Did you know? Over 2 million people are hospitalized each year for adverse reactions to prescription drugs. Over 2 million.
Copyright ©2008 by Pearson Education, Inc. Upper Saddle River, New Jersey All rights reserved. Focus on Pharmacology, First Edition By Jahangir Moini.
Foundation Knowledge and Skills
Pharmacogenomics: Improving the Dynamic of Care in Medication Management 1.
Copyright © 2016 by Elsevier, Inc. All rights reserved. Geropharmacology.
Chapters 6, 8, and 9 The Nursing Process, Drug Administration Throughout the Lifespan, Psychosocial, Gender and Cultural Influences on Pharmacotherapy.
Pharmacogenetics/Pharmacogenomics. Outline Introduction  Differential drug efficacy  People react differently to drugs Why does drug response vary?
Drug therapy in pediatric
Drug Therapy in Geriatric Patients
Drug Therapy in Pediatric Patients
Mahla sattarzadeh Kerman University of Medical Sciences
Factors affecting Drug Activity
Pharmacokinetics & Drug Dosing
Copyright Notice This presentation is copyrighted by the Psychopharmacology Institute. Subscribers can download it and use it for professional use. The.
Pharmacokinetics and Factors of Individual Variation
Therapeutic Drug Monitoring
Medication Administration for Pediatrics
Pharmacotherapy in Older Adults
Drug-drug Interactions
Pharmacology The science of Drugs.
POLYPHARMACY.
Presentation transcript:

Drug efficacy is questioned..

Variation in drug responses

Geriatrics Adults >65 years old Fastest growing population in US 20% of hospitalizations for those >65 are due to medications they’re taking

Decrease in total body water and increase in total body fat affects volume of distribution Water soluble drugs: lithium, aminoglycosides, alcohol, digoxin – Serum levels may go up due to decreased volume of distribution Fat soluble: diazepam, thiopental, trazadone – Half life increased with increase in body fat Pharmacokinetics

Metabolism Oxidative metabolism through cytochrome P450 system does decrease with aging, resulting in a decreased clearance of drugs

Excretion and Elimination GFR generally declines with aging, but is extremely variable 30% have little change 30% have moderate decrease 30% have severe decrease Serum creatinine is an unreliable marker, why???? If accuracy needed, do Cr Cl

Example: Creatinine Clearance vs. Age CrClScrAge

Pharmacodynamics (PD) Age-related changes: –  sensitivity to sedation and psychomotor impairment with benzodiazepines –  level and duration of pain relief with narcotic agents –  drowsiness and lateral sway with alcohol –  HR response to beta-blockers –  sensitivity to anti-cholinergic agents –  cardiac sensitivity to digoxin

Factors contributing to adverse drug reactions in elderly patients Polypharmacy How many prescription medications are too many? >4 or >6 Many elderly people receive 12 medications per day Heart, kidney, liver, thyroid Orthostatic hypotension, when they standup, blood goes to their feet - weak sympathetic nervous system response to constrict veins and increase heart rate. Low thyroid function causes lower body temperature, metabolic rate, & heart rate.

Pediatric Dosing Traditionally, for less frequently used drugs, extrapolation is done from adult dose on a weight or surface area basis. Problems Absorption may be more or less than adult Clearance of some drugs in children is affected by maturation, – Cytochrome P450 enzyme system matures over time – Glomerular filtration changes over time Drug targets may vary with age “Children are not Small Adults”

Examples CYP isoforms vary with age: For example, clearance of midazolam by CYP 3A4 and 3A5 goes from 1.2 ml/min/kg to 9 ml/min/kg over first few months of life Carbamezapine (3A4) clearance faster in children than adults – requires higher doses

SPECIAL CONSIDERATIONS IN PREGNANT AND BREASTFEEDING WOMEN IN PREGNANCY, THE DRUG IS REALLY GOING TO TWO PEOPLE, SO YOU MUST CONSIDER HOW THE DRUG MAY AFFECT THE GROWING FETUS. IMPORTANT FOR WOMEN TO AVOID AS MANY DRUGS AS POSSIBLE UNLESS ORDERED BY THE PHYSICIAN. TERATOGENIC—DRUGS THAT ARE LIKELY TO CAUSE MALFORMATIONS OR DAMAGE IN THE EMBRYO OR FETUS. THESE TYPE OF DRUGS SHOULD BE AVOIDED.

Impact of pregnancy on maternal pharmacodynamics ? GI absorption Reduction in gastric motility Reduction in gastric acid secretions Increases in gastric pH N/V of pregnancy Resultant decrease in a absorption and relative lower plasma drug concentrations

Difinitions Pharmacogenetics is the study of the effects of a drug in relation to a single or defined set of genes. Pharmacogenomics is the study of the effect of a drug in relation to the functions and interactions of all the genes in the genome. The goal rational means to optimize drug therapy and ensure maximum efficacy with minimal side effects.

Example African hypertensive diuretics ACEI and  -blockers. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. the first race-based prescription drug in the United States. (FDA) then approved (BiDil)

What is Personalized Medicine? Personalizedmedicinesimply means the prescription of specific treatments and therapeutics best suited for an individual's genetic makeup Personalized Medicine will enable doctors to: Use medications and other treatments that would work best for each individual Avoid medications that would cause an individual to have bad side effects

What are SNPs Single Nucleotide Polymorphisms –A SNP is a site of the DNA in which a single base-pair varies from person to person –They are the most common form of genetic variation in the human genome (frequency of >1%)

The basis of Genetic Diversity… Different arrangements of NUCLEOTIDES in a nucleic acid (DNA) provides the key to DIVERSITY among living organisms.

GCCCACCTCGCCCGCCTC Patient A Patient B Wild type Mutation Wild type Concentration Mutation Concentration Time CYP450 Same dose but different plasma concentrations Pharmacogenetics and Drug Metabolism